Bruce Y. Lee, MD, on the FDA’s Emergency Authorization of Remdesivir

In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized patients with severe COVID-19 as the pandemic progresses.

For more COVID-19 coverage, visit COVID-19 Care360.

References:


Bruce Y. Lee, MD, MBA, is a professor of Health Policy Management at the City University of New York, and an internationally-recognized expert in infectious disease, epidemic, and pandemic response, prevention, and control.

Submit Feedback

Name